Sanofi (ADR) (NYSE:SNY)

fda_logo

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks. These events refer to reviews and decisions by the U.S. Food ...
Read Full Story »
Volkswagen Golf 2015

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany’s Volkswagen. The automaker’s 2014 R&D spending will total $13.5 billion, just ahead of ...
Read Full Story »
Buffet

Significant Changes in Buffett and Berkshire Hathaway Holdings

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical changes on the surface, some of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More

Stocks are looking for direction on Wednesday with mixed indexes, but that is after another massive rally on Tuesday that took the DJIA back over 17,000 again. Earnings season is ...
Read Full Story »
Buffet

Major Portfolio Changes for Warren Buffett and Berkshire Hathaway

Berkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett's different portfolio holdings have not been changing much of late, but it turns ...
Read Full Story »
Stock Split Image

What the Market Is Telling MannKind (Updated)

MannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week's news that Sanofi (NYSE: SNY) will become its global partner for its inhalable insulin Afrezza. There has ...
Read Full Story »
76764023

MannKind Secures Future of Afrezza in Major Sanofi Deal

MannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of its strategy on how to get its Afrezza inhalable insulin ...
Read Full Story »
Pentagon, defense

Pentagon Awards $409 Million in Defense Contracts

The Department of Defense awarded 10 defense contracts totaling $408.9 million in its Friday evening announcement of contract awards. Among the publicly traded companies winning contracts: Hewlett Packard (NYSE: HPQ) ...
Read Full Story »
Buffet

Big Portfolio Changes for Warren Buffett and Berkshire Hathaway

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its holdings as of the end of the first quarter of 2014. We were originally not expecting many major changes to the portfolio. ...
Read Full Story »
Warren Buffett

Warren Buffett’s Nine Top Dividend Stocks

After finishing last year strong, U.S. equity markets had a volatile start this year, pulling back from all-time highs. Stocks have recovered since and, so far this year, the S&P ...
Read Full Story »
Buffet

Warren Buffett’s Top Dividend Stocks

Now that stocks have pulled back from their highs, some investors have moved on to more defensive stock positions. That move often lands some of the top dividend payers as ...
Read Full Story »
Warren Buffett

Meet the 2014 Warren Buffett and Berkshire Hathaway Stocks

As many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway Inc. (NYSE: BRK-A) ...
Read Full Story »
Monkey evil

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

It is the first full trading week of 2014, and investors are trying to decide how to position their portfolios for the year. Wall Street brokerage firms are making their ...
Read Full Story »
Warren Buffett

Buffett and Berkshire Hathaway Full Stock Holdings, Higher Again

Berkshire Hathaway Inc. (NYSE: BRK-A) and Warren Buffett have released the conglomerate's full stock holdings as of September 30, 2013. This 13F filing with the SEC shows that the company's ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »